• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

High IOP, uveitis lead to Posner-Schlossman diagnosis

Optometry Times JournalFebruary digital edition 2021
Volume 13
Issue 2

Controlling pressures key to preventing optic nerve damage

Treat what you see. I can’t remember from whom I learned that phrase, but a recent case really drove the point home for me.

Case presentation

A 31-year-old African male presented complaining of eye pain in his left eye for several days’ duration. He also stated that he had developed a headache right around that eye one day prior to his visit. He stated no vision change in either eye.

His medical history was remarkable for systemic hypertension, which was reportedly well controlled with a pill the name of which he was unsure. He has not lived in the United States for very long, and he reported being blind in his right, fellow eye for several years due to an infection related to contact lens wear when he was still living in Africa. His family history was noncontributory.

Related: Gonioscopy and imaging work in tandem

Clinical presentation

He presented wearing glasses with a low myopic prescription. Entering corrected visual acuities were 20/100 in the right eye and 20/25 in the left. Pupil testing was unremarkable, as was confrontation visual field assessment. Extraocular muscle testing showed full ranges of motion in each eye with no pain upon eye movements.

Intraocular pressures (IOP) were 16 mm Hg in the right eye and 44 mm Hg in the left by means of rebound tonometry in the mid-morning. Goldmann applanation tonometry revealed IOPs of 16 mm Hg in the right eye and 42 mm Hg in the left.

His conjunctiva was quiet in the right eye and had trace to Grade 1 injection in the left. The patient’s right cornea showed a central round stromal scar presumably from a previous corneal ulcer. The remainder of his right eye’s anterior segment was unremarkable.

Related: Navigate postop IOP control with wound burping

Specifically, his right anterior chamber was deep and quiet. The patient’s left cornea was remarkable for a small, faint round scar inferiorly as well as an area of small white keratic precipitates centrally (see Figure 1). The anterior chamber in that eye was remarkable for Grade 1 cells, which were moving well. There were no defects on the anterior lens capsule in either eye.

The patient’s angles were open to Grade 4 on von Herrick assessment. Gonioscopy also showed open angles, with each angle open to the ciliary body with flat iris approaches, mild trabecular meshwork pigment, and no blood or other obstructions in either eye.

Dilated posterior segment examination showed healthy retinas which were intact. There were no vascular abnormalities, and both optic nerve heads were intact and well perfused. Both vitreous humors were attached and quiet.

Related: Association found between laminar thinning and poor cognitive function


After considerable thought, I diagnosed this patient with Posner-Schlossman syndrome, also known by its arguably more sinister name, glaucomatocyclitic crisis. He stated no pulmonary diseases or conditions or difficulty breathing. His pulse was 74 beats per minute and had a regular rhythm.

I had a sample of Combigan (brimonidine tartrate/timolol maleate, Allergan) and instilled one drop in his left eye. He returned an hour and a half later as instructed, and his IOP in that eye had decreased to 24 mm Hg.

I informed the patient of his condition and prescribed timolol maleate 0.5% ophthalmic solution to be used once in the morning as well as prednisolone acetate ophthalmic suspension to be used every 2 hours while awake in the left eye. I invited him back the following morning for a follow-up examination.

Related: When good retinal surgery makes glaucoma go bad


The next morning, he reported good compliance with both of his drops and reported feeling better.

Distance visual acuity in the right eye was unchanged and was 20/20 in the left eye. Both conjunctivae were quiet. The cells in the left anterior chamber were still present but better and graded as trace. The keratic precipitates on the left cornea were unchanged.

IOPs by means of Goldmann applanation tonometry were 14 mm Hg in the right and 10 mm Hg in the left. I instructed him to stay on the same regimen with his drops and to return for follow-up care in 3 days.

At that time, the right eye was essentially unchanged. The left eye was still 20/20 corrected at distance. IOP in the mid-morning was 8 mm Hg in that eye, both anterior chambers were quiet, and the keratic precipitates on the left cornea were almost resolved completely.

Related: Aerie’s Rocklatan shows successful interim 90-day topline data

At that point, I instructed the patient to continue the timolol maleate every morning and tapered the prednisolone acetate to 4 times a day.

One week later, the patient’s anterior chamber remained clear, IOP was again 8 mm Hg, and the keratic precipitates had resolved completely.

I had the patient discontinue the timolol maleate and began further tapering the prednisolone acetate. A follow-up visit in another week was pending at the time I authored this manuscript.


Posner-Schlossman syndrome, also known as glaucomatocyclitic crisis, is an uncommon, unilateral, and often recurrent condition in which a patient is subject to high IOP along with mild nongranulomatous anterior uveitis.1 As such, small to medium fine keratic precipitates are also common.

Since it was first described,2 there has been much debate about the exact cause of this condition. More recently, there has been considerable evidence for a viral cause, with one study finding over 50% of study participants with Posner-Schlossman syndrome to have cytomegalovirus (CMV) in their aqueous humors as detected by means of polymerase chain reaction.3

The mainstays of treatment include controlling high IOP and decreasing inflammation. Controlling high IOP is particularly important because recurrent bouts of high IOP may lead to optic nerve damage.

Having not seen a case of this condition since my resident days at the hospital in Brooklyn (coupled with the fact that this particular presentation was in the patient’s good eye), I had to stop and think for an extended moment before wrapping my head around proper management.

I took extra time in performing gonioscopy in order to ensure I hadn’t overlooked any obstructions. I was happy that this patient was relatively straightforward to treat and is doing well, and I appreciated the opportunity to revisit this uncommon and potentially damaging clinical ocular condition.

More by Dr. Casella: In vivo bulbar conjunctival structures study results in


1. Maruyama K, Maruyama Y, Sugita S, Mori K, Yokoyama Y, Sanuki-Kunimatsu S, Nakagawa H, Kinoshita S, Mochizuki M, Nakazawa T. Characteristics of cases needing advanced treatment for intractable Posner–Schlossman syndrome. BMC Ophthalmol. 2017 Apr;17(1): 45.

2. Posner A, Schlossman A. Syndrome of unilateral recurrent attacks of glaucoma with cyclitic symptoms. Arch Ophthal. 1948 Apr;39(4):517-535.

3. Chee SP, Jap A. Presumed fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Am J Ophthalmol. 2008 Dec;146(6):883-889.e1.

Related Videos
Lorraine Provencher, MD, presenting slides
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
Michael Chaglasian, OD, details success of new OCT device at the ARVO 2024 meeting
Melissa Tawa, OD, FAAO
Deborah Ristvedt, DO, details CIME 2024 presentation on glaucoma management
Shan Lin, MD, speaks on Glaucoma 360 presentation in an interview with Ophthalmology Times
Danica Marrelli, OD, FAAO, AAO Dipl, co-chair of EnVision Summit chats about geographic atrophy and glaucoma panels
Nate Lighthizer, OD, speaks on lasers in optometry at AAOpt 2023
© 2024 MJH Life Sciences

All rights reserved.